Cargando…

Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia

Regulatory T (Tr) cells have the potential to treat immune-mediated disease, but cloning such cells for study from patients with autoimmune disease has proven difficult. Here, we describe autoantigen-specific, interleukin-10 (IL-10)–secreting Tr cell clones recovered ex vivo from a patient with auto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Frank J., Hall, Andrew M., Cairns, Lindsay S., Leggat, Arabella S., Urbaniak, Stanislaw J., Vickers, Mark A., Barker, Robert N.
Formato:	Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2008
Materias:	Immunobiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575838/ https://www.ncbi.nlm.nih.gov/pubmed/17761830 http://dx.doi.org/10.1182/blood-2007-07-101345

Ejemplares similares

Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation
por: Rowbotham, Nicola J., et al.
Publicado: (2007)

Evidence of dysregulation of dendritic cells in primary HIV infection
por: Sabado, Rachel Lubong, et al.
Publicado: (2010)

Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis
por: Meyer-Bahlburg, Almut, et al.
Publicado: (2008)

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
por: Law, Helen K.W., et al.
Publicado: (2005)

The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones
por: Gillet, Nicolas A., et al.
Publicado: (2011)

TCRζ(dim)lymphocytes define populations of circulating effector cells that migrate to inflamed tissues
por: Zhang, Zhuoli, et al.
Publicado: (2007)

SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation
por: Ahlfors, Helena, et al.
Publicado: (2010)

Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases
por: Martin Merinero, Héctor, et al.
Publicado: (2021)

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice
por: Hall, Lindsay S., et al.
Publicado: (2019)

High frequency of CD4(+)FoxP3(+) cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response
por: Toulza, Frederic, et al.
Publicado: (2008)

Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation
por: Xu, Heping, et al.
Publicado: (2008)

Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP
por: Bystrom, Jonas, et al.
Publicado: (2008)

Novel biphasic role for lymphocytes revealed during resolving inflammation
por: Rajakariar, Ravindra, et al.
Publicado: (2008)

Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma
por: Ferrari, Nicola, et al.
Publicado: (2021)

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease
por: Kinoshita, Hannah, et al.
Publicado: (2022)

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
por: Watanabe, Keisuke, et al.
Publicado: (2023)

Dangerous B-cell clones
por: Greinacher, Andreas, et al.
Publicado: (2022)

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
por: Kumar, Deepak, et al.
Publicado: (2022)

Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
por: Vogiatzi, Fotini, et al.
Publicado: (2022)

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies
por: Miljkovic, Milos D., et al.
Publicado: (2022)

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
por: Jiang, Wei, et al.
Publicado: (2022)

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
por: Bourbon, Estelle, et al.
Publicado: (2022)

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy
por: Little, Jessica S., et al.
Publicado: (2023)

Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8(+) T cells into B-cell follicles during HIV-1 infection
por: Ogunshola, Funsho J., et al.
Publicado: (2022)

Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
por: Chen, Chunxia, et al.
Publicado: (2020)

Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production
por: Lee, Jong Bok, et al.
Publicado: (2021)

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy
por: Holland, Elizabeth M., et al.
Publicado: (2022)

T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
por: Montironi, Chiara, et al.
Publicado: (2023)

Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation
por: Landy, Emily, et al.
Publicado: (2023)

Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
por: Diorio, Caroline, et al.
Publicado: (2022)

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
por: Lamble, Adam J., et al.
Publicado: (2022)

CD38 as a pan-hematologic target for chimeric antigen receptor T cells
por: Glisovic-Aplenc, Tina, et al.
Publicado: (2023)

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
por: Osman, Mohammed, et al.
Publicado: (2020)

Cytokine-induced natural killer cell training is dependent on cellular metabolism and is defective in obesity
por: Kedia-Mehta, Nidhi, et al.
Publicado: (2021)

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
por: Panetti, Silvia, et al.
Publicado: (2022)

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones
por: Shaw, Lauren C., et al.
Publicado: (2022)

Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy
por: Jalota, Akansha, et al.
Publicado: (2022)

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals
por: Philipp, Nora, et al.
Publicado: (2022)

Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia
por: Shahid, Sanam, et al.
Publicado: (2023)

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
por: Kambhampati, Swetha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap3m8u8cu9vpndjipdeg7g9p67